Posted On: 09/03/2014 4:12:35 AM
Post# of 273351
Abcam Plc (ABCZY) 7.1000 $ABCZY
Abcam Establishes New Direct Service for Australia and New Zealand
Business Wire - Tue Aug 12, 3:00AM CDT
Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam's focus on providing the best products and services to accelerate the pace of researchers' scientific discoveries.
Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million
M2 - Thu Jul 10, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gw724w/immunoprotein) has announced the addition of the "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million" report to their offering. The market for immunoprotein diagnostic testing has been segmented according to immunoprotein types which include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins. The market has also been segmented according to application in diagnosis of various diseases such as infectious diseases, allergy testing, endocrine testing, oncology testing, toxicology testing, and autoimmune disease testing. Further, the market has been studied from the perspective of technology platforms such as enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, radioimmunoassay, and immunoprotein electrophoresis. Geographically, the market has been segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). Each of the segments has been analyzed on the basis of current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - Abcam PLC - DiaSorin SPA - Enzo Life Sciences, Inc. - Fujirebio Diagnostics, Inc. - Omega Diagnostics Group PLC - Randox Laboratories Ltd. - Roche Holding AG - Siemens AG - The Binding Site Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/gw...unoprotein
Abcam Establishes New Direct Service for Australia and New Zealand
Business Wire - Tue Aug 12, 3:00AM CDT
Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam's focus on providing the best products and services to accelerate the pace of researchers' scientific discoveries.
Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million
M2 - Thu Jul 10, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gw724w/immunoprotein) has announced the addition of the "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million" report to their offering. The market for immunoprotein diagnostic testing has been segmented according to immunoprotein types which include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins. The market has also been segmented according to application in diagnosis of various diseases such as infectious diseases, allergy testing, endocrine testing, oncology testing, toxicology testing, and autoimmune disease testing. Further, the market has been studied from the perspective of technology platforms such as enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, radioimmunoassay, and immunoprotein electrophoresis. Geographically, the market has been segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). Each of the segments has been analyzed on the basis of current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - Abcam PLC - DiaSorin SPA - Enzo Life Sciences, Inc. - Fujirebio Diagnostics, Inc. - Omega Diagnostics Group PLC - Randox Laboratories Ltd. - Roche Holding AG - Siemens AG - The Binding Site Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/gw...unoprotein
(0)
(0)
